Skip to main content
. 2017 Apr 22;433(1):169–176. doi: 10.1007/s11010-017-3025-x

Fig. 3.

Fig. 3

Hyperoside does not inhibit oxLDL-induced ERK activation in VSMCs directly. a Cells were treated with hyperoside from 5 min to 1 h; b cells were pretreated with hyperoside and then treated with oxLDL. Western blot shows P-ERK activation. b, d the statistical results of (a, c) are (a) versus NC (P < 0.05), (b) versus NC (P > 0.05) and (c) versus oxLDL (P > 0.05). Results are from three independent experiments. NC negative control, H hyperoside